{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-26-000021","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2026-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.475119+00:00","generated_at":"2026-05-15T09:21:51.484097+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intensity Therapeutics expands at-the-market offering capacity to $60 million","bullets":["Filed prospectus supplement on March 23, 2026 to increase ATM program from prior cap to $60.0 million aggregate.","ATM conducted through H.C. Wainwright & Co. as sales agent under agreement dated July 3, 2024.","Company has no obligation to sell any shares; issuances at its discretion based on market conditions.","Expanded facility aims to enhance financial flexibility for strategic priorities and capital access."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-26-000021","json":"https://secwatch.observer/filing/0001567264-26-000021.json","markdown":"https://secwatch.observer/filing/0001567264-26-000021.md","text":"https://secwatch.observer/filing/0001567264-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000021/0001567264-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000021/intensity-20260323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:21:51.484097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}